Stem cell therapy may prevent PAD-related amputations

Patients with critical limb ischemia who received injections of stem cells derived from their bone marrow had a lower risk of amputation and death than patients who were not treated with the therapy in a Phase II clinical trial.

View Full Article in:

Stem Cells Improve Outlook for Severe PAD - DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT